Kyme Pierre (CIK 2028892) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-17). Recent activity: Sell ARMP (1,030 shares), Sell ARMP (1,027 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-17 | Armata Pharmaceuticals, Inc. (ARMP) | Chief Business Officer | Sell | 1,030 | $10,856 |
| 2025-04-25 | Armata Pharmaceuticals, Inc. (ARMP) | Chief Business Officer | Sell | 1,027 | $2,003 |
来源：SEC Form 4 申报文件 · 截至 2026-03-17